永昕生物醫藥股份有限公司

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022🗂️ Report periods on file: 2022

In its 2022 reporting, 永昕生物醫藥股份有限公司 disclosed greenhouse gas emissions of 1.6K tCO2e/year (2022). By scope: Scope 1: 3 tCO2e/year (2022); Scope 2: 1.6K tCO2e/year (2022). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
1.6K tCO2e/year (2022)
2022
💧
Water Usage
16.4K tons/year (2022)
2022
♻️
Waste
21.695 tons/year (2022)
2022
⚙️
Energy Use
2.8M kWh/year (2022)
2022

📊 Emissions by Scope (2022)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).3 tCO2e/year (2022)
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.1.6K tCO2e/year (2022)

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Complete GMP Phase 2 (Zhunan) filling line and cell therapy GMP plant.
  • Obtain regulatory certifications for GMP Phase 2 (Zhunan) and cell therapy GMP plant.
  • Construct a one-stop service platform for antibody-drug conjugates (ADCs) with Jianyi Biotech.

📅 Medium-term

  • Attract world-class pharmaceutical companies to join the new biopharmaceutical industry chain.
  • Continuously strengthen technology platforms and expand service areas.

🔭 Long-term

  • Become a world-class CDMO company specializing in cutting-edge technology and customized services.

🌱 ESG Focus Areas

EnvironmentalSocialGovernance

⚠️ Challenges & Risks +

  • Fluctuations in global economic conditions and post-COVID-19 changes.
  • Competition with international biopharmaceutical CDMO companies.
  • Lack of talent for expanding into the European and American markets.

📋 Report Information

Reporting Period: 2022